Virax Biolabs Group Limited fell 32.9% on Friday, November 6, 2026, on 1,103,624 shares. No headline about VRAX came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Virax Biolabs Group Limited (VRAX:NASDAQ) closed at $0.792 on November 6, 2026, down 32.89% on the day. The stock trades 96.4% below its 52-week high of $21.75 and 25.7% above its 52-week low of $0.630. Over the past year, it lost 93.2%. Virax Biolabs Group Limited is part of the Health Care sector.
In 252 trading sessions since November 6, 2025, VRAX closed higher on 89 days (35%). Its best day was July 9, 2026 (+100.00%) and its worst was July 10, 2026 (-35.85%). The stock moved 10% or more in a single session 39 times. It opened at least 5% above the previous day's high 10 times.
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of immunology.
Find more stocks like VRAX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.